VOCABRIA (cabotegravir) + REKAMBYS (rilpivirine) BMI data from OPERA
PM-GB-HVX-WCNT-220003 v10 | October 2026
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GSK via the GSK Reporting Tool or on 0800 221441.